Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1052486

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1052486

Global Preclinical CRO Market Insights and Forecast to 2028

PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

Market Analysis and Insights: Global Preclinical CRO Market

The global Preclinical CRO market size is projected to reach US$ 4880.9 million by 2028, from US$ 3452.8 million in 2021, at a CAGR of 4.6% during 2022-2028.

Fully considering the economic change by this health crisis, Security Evaluation Service accounting for % of the Preclinical CRO global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical Industry segment is altered to an % CAGR throughout this forecast period.

China Preclinical CRO market size is valued at US$ million in 2021, while the North America and Europe Preclinical CRO are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Preclinical CRO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical CRO market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical CRO market.

Global Preclinical CRO Scope and Market Size

Preclinical CRO market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Security Evaluation Service
  • Pharmacokinetic Research
  • Pharmacodynamic Research
  • Other

Segment by Application

  • Pharmaceutical Industry
  • Biotechnology

By Company

  • Charles River
  • Eurofins Scientific
  • Wuxi AppTec
  • Pharmaceutical Product Development (PPD), LLC
  • ICON Plc.
  • Labcorp
  • CRL
  • Crown Bioscience
  • Taconic Biosciences
  • Covance
  • EVOTEC
  • The Jackson Laboratory
  • MI Bioresearch
  • Champion Oncology
  • Xentech
  • Living Tumor Laboratory
  • JOINN Lab

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Preclinical CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Security Evaluation Service
    • 1.2.3 Pharmacokinetic Research
    • 1.2.4 Pharmacodynamic Research
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Preclinical CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical Industry
    • 1.3.3 Biotechnology
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Preclinical CRO Market Perspective (2017-2028)
  • 2.2 Preclinical CRO Growth Trends by Region
    • 2.2.1 Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Preclinical CRO Historic Market Size by Region (2017-2022)
    • 2.2.3 Preclinical CRO Forecasted Market Size by Region (2023-2028)
  • 2.3 Preclinical CRO Market Dynamics
    • 2.3.1 Preclinical CRO Industry Trends
    • 2.3.2 Preclinical CRO Market Drivers
    • 2.3.3 Preclinical CRO Market Challenges
    • 2.3.4 Preclinical CRO Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Preclinical CRO Players by Revenue
    • 3.1.1 Global Top Preclinical CRO Players by Revenue (2017-2022)
    • 3.1.2 Global Preclinical CRO Revenue Market Share by Players (2017-2022)
  • 3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Preclinical CRO Revenue
  • 3.4 Global Preclinical CRO Market Concentration Ratio
    • 3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2021
  • 3.5 Preclinical CRO Key Players Head office and Area Served
  • 3.6 Key Players Preclinical CRO Product Solution and Service
  • 3.7 Date of Enter into Preclinical CRO Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical CRO Breakdown Data by Type

  • 4.1 Global Preclinical CRO Historic Market Size by Type (2017-2022)
  • 4.2 Global Preclinical CRO Forecasted Market Size by Type (2023-2028)

5 Preclinical CRO Breakdown Data by Application

  • 5.1 Global Preclinical CRO Historic Market Size by Application (2017-2022)
  • 5.2 Global Preclinical CRO Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Preclinical CRO Market Size (2017-2028)
  • 6.2 North America Preclinical CRO Market Size by Type
    • 6.2.1 North America Preclinical CRO Market Size by Type (2017-2022)
    • 6.2.2 North America Preclinical CRO Market Size by Type (2023-2028)
    • 6.2.3 North America Preclinical CRO Market Share by Type (2017-2028)
  • 6.3 North America Preclinical CRO Market Size by Application
    • 6.3.1 North America Preclinical CRO Market Size by Application (2017-2022)
    • 6.3.2 North America Preclinical CRO Market Size by Application (2023-2028)
    • 6.3.3 North America Preclinical CRO Market Share by Application (2017-2028)
  • 6.4 North America Preclinical CRO Market Size by Country
    • 6.4.1 North America Preclinical CRO Market Size by Country (2017-2022)
    • 6.4.2 North America Preclinical CRO Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Preclinical CRO Market Size (2017-2028)
  • 7.2 Europe Preclinical CRO Market Size by Type
    • 7.2.1 Europe Preclinical CRO Market Size by Type (2017-2022)
    • 7.2.2 Europe Preclinical CRO Market Size by Type (2023-2028)
    • 7.2.3 Europe Preclinical CRO Market Share by Type (2017-2028)
  • 7.3 Europe Preclinical CRO Market Size by Application
    • 7.3.1 Europe Preclinical CRO Market Size by Application (2017-2022)
    • 7.3.2 Europe Preclinical CRO Market Size by Application (2023-2028)
    • 7.3.3 Europe Preclinical CRO Market Share by Application (2017-2028)
  • 7.4 Europe Preclinical CRO Market Size by Country
    • 7.4.1 Europe Preclinical CRO Market Size by Country (2017-2022)
    • 7.4.2 Europe Preclinical CRO Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Preclinical CRO Market Size (2017-2028)
  • 8.2 Asia-Pacific Preclinical CRO Market Size by Type
    • 8.2.1 Asia-Pacific Preclinical CRO Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Preclinical CRO Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Preclinical CRO Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Preclinical CRO Market Size by Application
    • 8.3.1 Asia-Pacific Preclinical CRO Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Preclinical CRO Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Preclinical CRO Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Preclinical CRO Market Size by Region
    • 8.4.1 Asia-Pacific Preclinical CRO Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Preclinical CRO Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Preclinical CRO Market Size (2017-2028)
  • 9.2 Latin America Preclinical CRO Market Size by Type
    • 9.2.1 Latin America Preclinical CRO Market Size by Type (2017-2022)
    • 9.2.2 Latin America Preclinical CRO Market Size by Type (2023-2028)
    • 9.2.3 Latin America Preclinical CRO Market Share by Type (2017-2028)
  • 9.3 Latin America Preclinical CRO Market Size by Application
    • 9.3.1 Latin America Preclinical CRO Market Size by Application (2017-2022)
    • 9.3.2 Latin America Preclinical CRO Market Size by Application (2023-2028)
    • 9.3.3 Latin America Preclinical CRO Market Share by Application (2017-2028)
  • 9.4 Latin America Preclinical CRO Market Size by Country
    • 9.4.1 Latin America Preclinical CRO Market Size by Country (2017-2022)
    • 9.4.2 Latin America Preclinical CRO Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Preclinical CRO Market Size (2017-2028)
  • 10.2 Middle East & Africa Preclinical CRO Market Size by Type
    • 10.2.1 Middle East & Africa Preclinical CRO Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Preclinical CRO Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Preclinical CRO Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Preclinical CRO Market Size by Application
    • 10.3.1 Middle East & Africa Preclinical CRO Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Preclinical CRO Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Preclinical CRO Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Preclinical CRO Market Size by Country
    • 10.4.1 Middle East & Africa Preclinical CRO Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Preclinical CRO Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Charles River
    • 11.1.1 Charles River Company Details
    • 11.1.2 Charles River Business Overview
    • 11.1.3 Charles River Preclinical CRO Introduction
    • 11.1.4 Charles River Revenue in Preclinical CRO Business (2017-2022)
    • 11.1.5 Charles River Recent Developments
  • 11.2 Eurofins Scientific
    • 11.2.1 Eurofins Scientific Company Details
    • 11.2.2 Eurofins Scientific Business Overview
    • 11.2.3 Eurofins Scientific Preclinical CRO Introduction
    • 11.2.4 Eurofins Scientific Revenue in Preclinical CRO Business (2017-2022)
    • 11.2.5 Eurofins Scientific Recent Developments
  • 11.3 Wuxi AppTec
    • 11.3.1 Wuxi AppTec Company Details
    • 11.3.2 Wuxi AppTec Business Overview
    • 11.3.3 Wuxi AppTec Preclinical CRO Introduction
    • 11.3.4 Wuxi AppTec Revenue in Preclinical CRO Business (2017-2022)
    • 11.3.5 Wuxi AppTec Recent Developments
  • 11.4 Pharmaceutical Product Development (PPD), LLC
    • 11.4.1 Pharmaceutical Product Development (PPD), LLC Company Details
    • 11.4.2 Pharmaceutical Product Development (PPD), LLC Business Overview
    • 11.4.3 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Introduction
    • 11.4.4 Pharmaceutical Product Development (PPD), LLC Revenue in Preclinical CRO Business (2017-2022)
    • 11.4.5 Pharmaceutical Product Development (PPD), LLC Recent Developments
  • 11.5 ICON Plc.
    • 11.5.1 ICON Plc. Company Details
    • 11.5.2 ICON Plc. Business Overview
    • 11.5.3 ICON Plc. Preclinical CRO Introduction
    • 11.5.4 ICON Plc. Revenue in Preclinical CRO Business (2017-2022)
    • 11.5.5 ICON Plc. Recent Developments
  • 11.6 Labcorp
    • 11.6.1 Labcorp Company Details
    • 11.6.2 Labcorp Business Overview
    • 11.6.3 Labcorp Preclinical CRO Introduction
    • 11.6.4 Labcorp Revenue in Preclinical CRO Business (2017-2022)
    • 11.6.5 Labcorp Recent Developments
  • 11.7 CRL
    • 11.7.1 CRL Company Details
    • 11.7.2 CRL Business Overview
    • 11.7.3 CRL Preclinical CRO Introduction
    • 11.7.4 CRL Revenue in Preclinical CRO Business (2017-2022)
    • 11.7.5 CRL Recent Developments
  • 11.8 Crown Bioscience
    • 11.8.1 Crown Bioscience Company Details
    • 11.8.2 Crown Bioscience Business Overview
    • 11.8.3 Crown Bioscience Preclinical CRO Introduction
    • 11.8.4 Crown Bioscience Revenue in Preclinical CRO Business (2017-2022)
    • 11.8.5 Crown Bioscience Recent Developments
  • 11.9 Taconic Biosciences
    • 11.9.1 Taconic Biosciences Company Details
    • 11.9.2 Taconic Biosciences Business Overview
    • 11.9.3 Taconic Biosciences Preclinical CRO Introduction
    • 11.9.4 Taconic Biosciences Revenue in Preclinical CRO Business (2017-2022)
    • 11.9.5 Taconic Biosciences Recent Developments
  • 11.10 Covance
    • 11.10.1 Covance Company Details
    • 11.10.2 Covance Business Overview
    • 11.10.3 Covance Preclinical CRO Introduction
    • 11.10.4 Covance Revenue in Preclinical CRO Business (2017-2022)
    • 11.10.5 Covance Recent Developments
  • 11.11 EVOTEC
    • 11.11.1 EVOTEC Company Details
    • 11.11.2 EVOTEC Business Overview
    • 11.11.3 EVOTEC Preclinical CRO Introduction
    • 11.11.4 EVOTEC Revenue in Preclinical CRO Business (2017-2022)
    • 11.11.5 EVOTEC Recent Developments
  • 11.12 The Jackson Laboratory
    • 11.12.1 The Jackson Laboratory Company Details
    • 11.12.2 The Jackson Laboratory Business Overview
    • 11.12.3 The Jackson Laboratory Preclinical CRO Introduction
    • 11.12.4 The Jackson Laboratory Revenue in Preclinical CRO Business (2017-2022)
    • 11.12.5 The Jackson Laboratory Recent Developments
  • 11.13 MI Bioresearch
    • 11.13.1 MI Bioresearch Company Details
    • 11.13.2 MI Bioresearch Business Overview
    • 11.13.3 MI Bioresearch Preclinical CRO Introduction
    • 11.13.4 MI Bioresearch Revenue in Preclinical CRO Business (2017-2022)
    • 11.13.5 MI Bioresearch Recent Developments
  • 11.14 Champion Oncology
    • 11.14.1 Champion Oncology Company Details
    • 11.14.2 Champion Oncology Business Overview
    • 11.14.3 Champion Oncology Preclinical CRO Introduction
    • 11.14.4 Champion Oncology Revenue in Preclinical CRO Business (2017-2022)
    • 11.14.5 Champion Oncology Recent Developments
  • 11.15 Xentech
    • 11.15.1 Xentech Company Details
    • 11.15.2 Xentech Business Overview
    • 11.15.3 Xentech Preclinical CRO Introduction
    • 11.15.4 Xentech Revenue in Preclinical CRO Business (2017-2022)
    • 11.15.5 Xentech Recent Developments
  • 11.16 Living Tumor Laboratory
    • 11.16.1 Living Tumor Laboratory Company Details
    • 11.16.2 Living Tumor Laboratory Business Overview
    • 11.16.3 Living Tumor Laboratory Preclinical CRO Introduction
    • 11.16.4 Living Tumor Laboratory Revenue in Preclinical CRO Business (2017-2022)
    • 11.16.5 Living Tumor Laboratory Recent Developments
  • 11.17 JOINN Lab
    • 11.17.1 JOINN Lab Company Details
    • 11.17.2 JOINN Lab Business Overview
    • 11.17.3 JOINN Lab Preclinical CRO Introduction
    • 11.17.4 JOINN Lab Revenue in Preclinical CRO Business (2017-2022)
    • 11.17.5 JOINN Lab Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Preclinical CRO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Security Evaluation Service
  • Table 3. Key Players of Pharmacokinetic Research
  • Table 4. Key Players of Pharmacodynamic Research
  • Table 5. Key Players of Other
  • Table 6. Global Preclinical CRO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Preclinical CRO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Preclinical CRO Market Share by Region (2017-2022)
  • Table 10. Global Preclinical CRO Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Preclinical CRO Market Share by Region (2023-2028)
  • Table 12. Preclinical CRO Market Trends
  • Table 13. Preclinical CRO Market Drivers
  • Table 14. Preclinical CRO Market Challenges
  • Table 15. Preclinical CRO Market Restraints
  • Table 16. Global Preclinical CRO Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Preclinical CRO Revenue Share by Players (2017-2022)
  • Table 18. Global Top Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2021)
  • Table 19. Ranking of Global Top Preclinical CRO Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Preclinical CRO Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Preclinical CRO Product Solution and Service
  • Table 23. Date of Enter into Preclinical CRO Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Preclinical CRO Revenue Market Share by Type (2017-2022)
  • Table 27. Global Preclinical CRO Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Preclinical CRO Revenue Market Share by Type (2023-2028)
  • Table 29. Global Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Preclinical CRO Revenue Share by Application (2017-2022)
  • Table 31. Global Preclinical CRO Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Preclinical CRO Revenue Share by Application (2023-2028)
  • Table 33. North America Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Preclinical CRO Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Charles River Company Details
  • Table 64. Charles River Business Overview
  • Table 65. Charles River Preclinical CRO Product
  • Table 66. Charles River Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 67. Charles River Recent Developments
  • Table 68. Eurofins Scientific Company Details
  • Table 69. Eurofins Scientific Business Overview
  • Table 70. Eurofins Scientific Preclinical CRO Product
  • Table 71. Eurofins Scientific Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 72. Eurofins Scientific Recent Developments
  • Table 73. Wuxi AppTec Company Details
  • Table 74. Wuxi AppTec Business Overview
  • Table 75. Wuxi AppTec Preclinical CRO Product
  • Table 76. Wuxi AppTec Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 77. Wuxi AppTec Recent Developments
  • Table 78. Pharmaceutical Product Development (PPD), LLC Company Details
  • Table 79. Pharmaceutical Product Development (PPD), LLC Business Overview
  • Table 80. Pharmaceutical Product Development (PPD), LLC Preclinical CRO Product
  • Table 81. Pharmaceutical Product Development (PPD), LLC Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 82. Pharmaceutical Product Development (PPD), LLC Recent Developments
  • Table 83. ICON Plc. Company Details
  • Table 84. ICON Plc. Business Overview
  • Table 85. ICON Plc. Preclinical CRO Product
  • Table 86. ICON Plc. Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 87. ICON Plc. Recent Developments
  • Table 88. Labcorp Company Details
  • Table 89. Labcorp Business Overview
  • Table 90. Labcorp Preclinical CRO Product
  • Table 91. Labcorp Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 92. Labcorp Recent Developments
  • Table 93. CRL Company Details
  • Table 94. CRL Business Overview
  • Table 95. CRL Preclinical CRO Product
  • Table 96. CRL Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 97. CRL Recent Developments
  • Table 98. Crown Bioscience Company Details
  • Table 99. Crown Bioscience Business Overview
  • Table 100. Crown Bioscience Preclinical CRO Product
  • Table 101. Crown Bioscience Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 102. Crown Bioscience Recent Developments
  • Table 103. Taconic Biosciences Company Details
  • Table 104. Taconic Biosciences Business Overview
  • Table 105. Taconic Biosciences Preclinical CRO Product
  • Table 106. Taconic Biosciences Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 107. Taconic Biosciences Recent Developments
  • Table 108. Covance Company Details
  • Table 109. Covance Business Overview
  • Table 110. Covance Preclinical CRO Product
  • Table 111. Covance Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 112. Covance Recent Developments
  • Table 113. EVOTEC Company Details
  • Table 114. EVOTEC Business Overview
  • Table 115. EVOTEC Preclinical CRO Product
  • Table 116. EVOTEC Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 117. EVOTEC Recent Developments
  • Table 118. The Jackson Laboratory Company Details
  • Table 119. The Jackson Laboratory Business Overview
  • Table 120. The Jackson Laboratory Preclinical CRO Product
  • Table 121. The Jackson Laboratory Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 122. The Jackson Laboratory Recent Developments
  • Table 123. MI Bioresearch Company Details
  • Table 124. MI Bioresearch Business Overview
  • Table 125. MI Bioresearch Preclinical CRO Product
  • Table 126. MI Bioresearch Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 127. MI Bioresearch Recent Developments
  • Table 128. Champion Oncology Company Details
  • Table 129. Champion Oncology Business Overview
  • Table 130. Champion Oncology Preclinical CRO Product
  • Table 131. Champion Oncology Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 132. Champion Oncology Recent Developments
  • Table 133. Xentech Company Details
  • Table 134. Xentech Business Overview
  • Table 135. Xentech Preclinical CRO Product
  • Table 136. Xentech Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 137. Xentech Recent Developments
  • Table 138. Living Tumor Laboratory Company Details
  • Table 139. Living Tumor Laboratory Business Overview
  • Table 140. Living Tumor Laboratory Preclinical CRO Product
  • Table 141. Living Tumor Laboratory Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 142. Living Tumor Laboratory Recent Developments
  • Table 143. JOINN Lab Company Details
  • Table 144. JOINN Lab Business Overview
  • Table 145. JOINN Lab Preclinical CRO Product
  • Table 146. JOINN Lab Revenue in Preclinical CRO Business (2017-2022) & (US$ Million)
  • Table 147. JOINN Lab Recent Developments
  • Table 148. Research Programs/Design for This Report
  • Table 149. Key Data Information from Secondary Sources
  • Table 150. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Preclinical CRO Market Share by Type: 2021 VS 2028
  • Figure 2. Security Evaluation Service Features
  • Figure 3. Pharmacokinetic Research Features
  • Figure 4. Pharmacodynamic Research Features
  • Figure 5. Other Features
  • Figure 6. Global Preclinical CRO Market Share by Application: 2021 VS 2028
  • Figure 7. Pharmaceutical Industry Case Studies
  • Figure 8. Biotechnology Case Studies
  • Figure 9. Preclinical CRO Report Years Considered
  • Figure 10. Global Preclinical CRO Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Preclinical CRO Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Preclinical CRO Market Share by Region: 2021 VS 2028
  • Figure 13. Global Preclinical CRO Market Share by Players in 2021
  • Figure 14. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Preclinical CRO Revenue in 2021
  • Figure 16. North America Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Preclinical CRO Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Preclinical CRO Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Preclinical CRO Market Size Share by Country (2017-2028)
  • Figure 20. United States Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Preclinical CRO Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Preclinical CRO Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Preclinical CRO Market Size Share by Country (2017-2028)
  • Figure 26. Germany Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Preclinical CRO Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Preclinical CRO Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Preclinical CRO Market Size Share by Region (2017-2028)
  • Figure 36. China Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Latin America Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Preclinical CRO Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Preclinical CRO Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Preclinical CRO Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Preclinical CRO Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Preclinical CRO Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Preclinical CRO Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Charles River Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 56. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 57. Wuxi AppTec Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 58. Pharmaceutical Product Development (PPD), LLC Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 59. ICON Plc. Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 60. Labcorp Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 61. CRL Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 62. Crown Bioscience Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 63. Taconic Biosciences Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 64. Covance Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 65. EVOTEC Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 66. The Jackson Laboratory Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 67. MI Bioresearch Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 68. Champion Oncology Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 69. Xentech Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 70. Living Tumor Laboratory Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 71. JOINN Lab Revenue Growth Rate in Preclinical CRO Business (2017-2022)
  • Figure 72. Bottom-up and Top-down Approaches for This Report
  • Figure 73. Data Triangulation
  • Figure 74. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!